Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system.
Streptococcus pyogenes, an important human pathogen, expresses several proteins that interact with the immune system of the host. Among the proteins isolated from different bacterial strains are antiphagocytic M proteins, Ig Fc-binding proteins and exotoxins that act as superantigens. Here we report a novel interaction between S. pyogenes and the human immune system, the ability of most S. pyogenes strains to bind human C4BP (C4b-binding protein), a 570-kDa serum protein that inhibits the classical pathway of complement activation. Molecular analysis of three different streptococcal strains demonstrated that C4BP binds to protein Arp or protein Sir, two Ig-binding cell surface molecules that are members of the M protein family. These bacterial proteins have separate high affinity binding sites for Ig and for C4BP, as demonstrated by inhibition tests and binding assays with purified components. A single streptococcal cell surface molecule, Arp or Sir, therefore combines the abilities to bind Ig and C4BP, two high m.w. components of the immune system. Two bacterial strains expressing Arp or Sir were shown to selectively bind C4BP in whole human serum, suggesting that S. pyogenes also binds C4BP in the infected host. When bound to streptococcal cells, C4BP retained its ability to act as a cofactor in the degradation of C4b by factor I. These results indicate that many strains of S. pyogenes interfere with the classical pathway of complement activation by binding C4BP to the bacterial cell surface.
Thern
A
A
Department of Medical Microbiology, Lund University, Sölvegatan, Sweden.
Stenberg
L
L
Dahlbäck
B
B
Lindahl
G
G
D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins / Q000378:metabolism*; D002135:Calcium-Binding Proteins / Q000378:metabolism*; D002352:Carrier Proteins / Q000378:metabolism*; D003171:Complement Pathway, Classical; D006801:Humans; D007136:Immunoglobulins / Q000378:metabolism*; D016167:Integrin alphaXbeta2; D008024:Ligands; D008565:Membrane Proteins / Q000378:metabolism*; D005810:Multigene Family; D009414:Nerve Growth Factors; D011506:Proteins; D015800:Protozoan Proteins; D013290:Streptococcal Infections / Q000382:microbiology; D013297:Streptococcus pyogenes / Q000145:classification / Q000302:isolation & purification / Q000378:metabolism*
D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D002135:Calcium-Binding Proteins; D002352:Carrier Proteins; C087175:Emm22 protein,Streptococcus pyogenes; D007136:Immunoglobulins; D016167:Integrin alphaXbeta2; D008024:Ligands; C099695:MANF protein, human; D008565:Membrane Proteins; D009414:Nerve Growth Factors; D011506:Proteins; D015800:Protozoan Proteins; C079235:acidic repeat protein, Euglena gracilis; C014689:streptococcal M protein